Lexeo Therapeutics reported total assets of $254.90M and total liabilities of $19.84M for the quarter ended Jun 2026, up 44.8% year over year. This balance sheet covers 16 quarters of results from Sep 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.13M | 0.32M | 0.38M | 0.45M | 0.53M | 0.61M | 0.47M | 0.53M | 0.60M | 0.67M | 0.74M | 0.81M | 0.89M | |||
| Assets | ||||||||||||||||
| Current Assets | ||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 94.15M | 77.33M | 35.45M | 121.47M | 195.10M | 175.00M | 157.02M | 35.01M | 106.90M | 35.48M | 41.00M | 63.00M | 71.77M | 92.83M | ||
| Prepaid Assets | 2.34M | 2.01M | 2.83M | 3.03M | 2.17M | 2.44M | 4.60M | 5.44M | 7.17M | 5.03M | 6.62M | 7.82M | 6.21M | |||
| Current Assets | 80.05M | 38.87M | 124.29M | 198.09M | 177.15M | 159.46M | 126.12M | 105.27M | 140.06M | 127.79M | 188.39M | 200.86M | 217.91M | |||
| Non-Current Assets | ||||||||||||||||
| Property, Plant & Equipment (Net) | 1.00M | 0.98M | 1.06M | 1.04M | 1.21M | 1.18M | 1.03M | 1.04M | 1.11M | 1.23M | 1.14M | 1.10M | 1.12M | |||
| Long-Term Investments | 7.01M | 7.04M | 19.61M | 3.39M | 64.80M | 34.51M | 22.47M | |||||||||
| Other Non-Current Assets | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | ||
| Non-Current Assets | 17.03M | 15.85M | 15.51M | 15.12M | 14.86M | 14.41M | 20.82M | 20.42M | 36.01M | 16.05M | 80.30M | 49.49M | 36.99M | |||
| Assets | 97.08M | 54.72M | 139.81M | 213.21M | 192.01M | 173.87M | 146.94M | 125.69M | 176.07M | 143.84M | 268.69M | 250.36M | 254.90M | |||
| Liabilities | ||||||||||||||||
| Current Liabilities | ||||||||||||||||
| Accounts Payables | 2.68M | 2.65M | 3.79M | 4.30M | 5.76M | 8.44M | 6.42M | 11.98M | 20.02M | 4.66M | 4.86M | 3.33M | 4.18M | |||
| Notes Payables | 4.15M | |||||||||||||||
| Payables | 2.68M | 6.80M | 3.79M | 4.30M | 5.76M | 8.44M | 6.42M | 11.98M | 20.02M | 4.66M | 4.86M | 3.33M | 4.18M | |||
| Accumulated Expenses | 6.42M | 11.80M | 10.84M | 13.77M | 10.44M | 15.70M | 13.76M | 16.20M | 8.91M | 9.90M | 9.28M | 8.16M | 8.85M | |||
| Other Accumulated Expenses | 0.24M | 0.18M | 0.55M | 0.18M | 0.18M | 0.55M | 0.55M | 0.67M | 0.19M | 0.21M | 0.07M | 0.10M | 0.27M | |||
| Current Leases | 2.29M | 2.08M | 2.09M | 2.09M | 2.10M | 2.11M | 2.10M | 2.13M | 2.14M | 2.15M | 2.16M | 2.17M | 2.18M | |||
| Current Taxes | 0.51M | 0.02M | 0.16M | 0.15M | 0.04M | |||||||||||
| Total Current Liabilities | 14.35M | 23.04M | 17.24M | 21.63M | 18.88M | 26.82M | 22.85M | 30.82M | 31.59M | 17.27M | 16.81M | 14.19M | 15.69M | |||
| Non-Current Liabilities | ||||||||||||||||
| Capital Leases | 1.65M | 1.35M | 1.25M | 1.15M | 1.04M | 0.93M | 0.82M | 0.70M | 0.58M | 0.45M | 0.33M | 0.20M | 0.10M | |||
| Preferred Stock Liabilities | 185.03M | 185.03M | 185.03M | 185.03M | 185.03M | |||||||||||
| Operating Leases | 9.00M | 8.11M | 7.79M | 7.47M | 7.14M | 6.79M | 6.44M | 6.05M | 5.68M | 5.29M | 4.88M | 4.47M | 4.05M | |||
| Other Non-Current Liabilities | 4.10M | |||||||||||||||
| Total Non-Current Liabilities | 28.40M | |||||||||||||||
| Total Liabilities | 98.98M | 25.00M | 131.18M | 143.62M | 32.50M | 26.27M | 30.25M | 27.06M | 34.54M | 30.10M | 37.58M | 37.85M | 23.01M | 22.02M | 18.86M | 19.84M |
| Shareholder's Equity | ||||||||||||||||
| Total Debt | 4.15M | |||||||||||||||
| Common Equity | -98.98M | -112.95M | -131.18M | -143.62M | -162.81M | 113.53M | 182.95M | 164.95M | 139.33M | 116.84M | 88.11M | 138.22M | 120.83M | 246.67M | 231.50M | 235.06M |
| Liabilities and Shareholders Equity | 97.08M | 54.72M | 139.81M | 213.21M | 192.01M | 173.87M | 146.94M | 125.69M | 176.07M | 143.84M | 268.69M | 250.36M | 254.90M | |||
| Treasury Shares | 143.65M | 143.65M | 143.65M | 143.65M | 143.65M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | ||
| Retained Earnings | -115.45M | -167.65M | -181.84M | -224.80M | -224.76M | -254.25M | -280.17M | -312.83M | -338.93M | -359.21M | -380.13M | -400.33M | -426.20M | |||
| Preferred Shares | 185.56M |